Recombinant human interleukin 10 for induction of remission in Crohn's disease
Editorial Group: Cochrane IBD Group
Published Online: 10 NOV 2010
Assessed as up-to-date: 17 SEP 2010
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Buruiana FE, Solà I, Alonso-Coello P. Recombinant human interleukin 10 for induction of remission in Crohn's disease. Cochrane Database of Systematic Reviews 2010, Issue 11. Art. No.: CD005109. DOI: 10.1002/14651858.CD005109.pub3.
- Publication Status: Edited (no change to conclusions)
- Published Online: 10 NOV 2010
This article has been cited by:
- 2Experimental colitis models: Insights into the pathogenesis of inflammatory bowel disease and translational issues, European Journal of Pharmacology, 2015, 759, 253, , ,
- 3Interleukin-10 paradox: A potent immunoregulatory cytokine that has been difficult to harness for immunotherapy, Cytokine, 2015, 74, 1, 27, , , , , ,
- 4Laboratory Medicine to improve biological therapeutic treatment, La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine, 2015, 11, 1, 29, , , , ,
- 52014,, , , , , , , ,
- 6Colitis ulcerosa, coloproctology, 2012, 34, 6, 401, ,
- 7Quince (Cydonia oblonga Miller) peel polyphenols modulate LPS-induced inflammation in human THP-1-derived macrophages through NF-κB, p38MAPK and Akt inhibition, Biochemical and Biophysical Research Communications, 2012, 418, 1, 180, , , , , ,